Sodium calcium edetate (EDTA), also known as edetate calcium disodium, is an intravenous heavy metal chelating agent primarily used in the treatment of severe lead poisoning. Use of this medication is often referred to as EDTA therapy, and is usually administered concurrently with dimercaprol (BAL) continuously for a maximum of 5 days.
